University of Florida, Institute of Food and Agricultural Sciences, Range Cattle Research and Education Center, Ona 33865, USA.
J Anim Sci. 2013 Apr;91(4):1831-7. doi: 10.2527/jas.2012-5724. Epub 2013 Jan 23.
Two experiments were conducted to evaluate the influence of vaccination on the acute-phase protein (APP) reaction (Exp. 1 and 2) and measures of performance (Exp. 2) in growing beef calves. In Exp. 1, the APP reaction was assessed in newly weaned steers administered 1 of 3 treatments (n = 8 steers/treatment), consisting of 1) Mannheimia haemolytica vaccine (One Shot; Pfizer Inc., New York, NY), 2) Clostridium vaccine (UltraBac 7; Pfizer, Inc.), or 3) saline-injected control. Blood samples for the evaluation of APP concentrations were collected on d 0, 1, 3, 5, 7, 10, and 14 and steer BW measured on d 0 and 21 relative to treatment administration. Plasma concentrations of haptoglobin (Hp) increased (P < 0.05) in vaccinated but not control calves and reached a peak on d 3 and 5 for steers receiving Mannheimia haemolytica and Clostridium vaccine, respectively. Plasma concentrations of ceruloplasmin (Cp) and fibrinogen (Fb) increased (P < 0.05) in all calves after treatment administration and Fb concentrations were greatest (P < 0.01) in calves receiving Mannheimia haemolytica vaccine on d 3 and 5 compared with the other treatments. There were no treatment effects (P = 0.44) on 21-d steer ADG (0.43 kg/d; SEM = 0.082). In Exp. 2, 23 heifers were randomly assigned to 2 treatments: 1) vaccinated (Mannheimia haemolytica vaccine (One Shot; n = 12) and 2) saline control (n = 11). After vaccination, blood samples were collected for determination of APP concentrations on d 0, 3, 6, 9, 12, and 15. During this period, individual heifer DMI was measured using an automated feed intake measuring system (Model 4000E; GrowSafe Systems Ltd., Airdrie, Alberta, Canada). Initial and final shrunk BW did not differ (P > 0.36) among treatments. On d 1, plasma Cp concentrations increased (P < 0.01) sharply in vaccinated heifers but not control heifers and were greater (P < 0.05) in vaccinated vs. control heifers on d 3, 6, 9, and 12 relative to injection. Daily DMI did not differ (P = 0.66) among treatments (average = 9.1 kg/d; SEM = 0.34); however, ADG and G:F were greater (P ≤ 0.05) for control vs. vaccinated heifers (1.14 vs. 0.87 kg/d and 0.13 and 0.10 kg, respectively; SEM = 0.064 and 0.011). These data indicate that within a 2 wk period after vaccination, beef calves experience an acute-phase protein response, which may result in reduced ADG and feed efficiency.
进行了两项实验来评估疫苗接种对生长肉牛的急性期蛋白(APP)反应(实验 1 和 2)和性能测量(实验 2)的影响。在实验 1 中,评估了新断奶的小公牛接受 3 种处理(每组 8 头小公牛)后的 APP 反应,包括 1)黏膜病嗜血杆菌疫苗(One Shot;辉瑞公司,纽约州,NY),2)梭菌疫苗(UltraBac 7;辉瑞公司),或 3)生理盐水注射对照。在接种处理后的第 0、1、3、5、7、10 和 14 天以及相对接种处理的第 21 天采集血液样本,用于评估 APP 浓度,同时测量小公牛的体重。接种疫苗的小公牛(但不是对照小公牛)的触珠蛋白(Hp)浓度升高(P < 0.05),并分别在接种后的第 3 天和第 5 天达到峰值,接受曼海姆氏菌和梭菌疫苗的小公牛的血浆铜蓝蛋白(Cp)和纤维蛋白原(Fb)浓度也升高(P < 0.05)。在接种处理后,所有小公牛的 Fb 浓度都升高(P < 0.05),接受曼海姆氏菌疫苗的小公牛的 Fb 浓度在第 3 天和第 5 天最高(P < 0.01),与其他处理相比。21 天小公牛的平均日增重(0.43 千克/天;SEM = 0.082)没有处理效应(P = 0.44)。在实验 2 中,23 头小母牛被随机分配到 2 种处理:1)接种(曼海姆氏菌疫苗(One Shot;n = 12)和 2)生理盐水对照(n = 11)。接种后,在第 0、3、6、9、12 和 15 天采集血液样本,用于测定 APP 浓度。在此期间,使用自动饲料摄入量测量系统(Model 4000E;GrowSafe Systems Ltd.,艾伯塔省,加拿大)测量个体小母牛的采食量。初始和最终的收缩体重在处理之间没有差异(P > 0.36)。在第 1 天,接种疫苗的小母牛的 Cp 浓度急剧升高(P < 0.01),但对照小母牛的 Cp 浓度没有升高,与对照小母牛相比,接种疫苗的小母牛的 Cp 浓度在第 3、6、9 和 12 天注射后更高(P < 0.05)。处理之间的每日采食量没有差异(P = 0.66)(平均为 9.1 千克/天;SEM = 0.34);然而,对照小母牛的 ADG 和饲料效率更高(P ≤ 0.05),比接种疫苗的小母牛分别高 0.14 千克/天(0.13 和 0.10 千克;SEM = 0.064 和 0.011)。这些数据表明,在接种后 2 周内,肉牛经历了急性期蛋白反应,这可能导致 ADG 和饲料效率降低。